Interim report 1 January - 30 September 2009
(Thomson Reuters ONE) - Interim report 1 January - 30 September 2009- Net sales amounted to SEK 151.2 million (106.0), an increase of SEK45.2 million (43%).- Operating profit was SEK 36.4 million (18.4), an increase of SEK 18million.- Profit before tax was SEK 42.6 million (20.1), an increase of SEK22.5 million.- Due to the earlier cumulative loss carry forward, BioGaia pays notax. Profit after reported tax was SEK 29.3 million (31.1), adecrease of SEK 1.8 million. The period's reported tax expense of SEK13.3 million refers to a change in the deferred tax asset. Profit forthe corresponding period of last year included a deferred tax benefitof SEK 11.0 million.- Earnings per share after reported tax amounted to SEK 1.70 (1.81).- The period's cash flow from operating activities before change inworking capital was SEK 40.0 million (23.3). Total cash flow for theperiod was SEK 29.7 million (15.7). Cash and cash equivalents at 30September 2009 amounted to SEK 87.5 million.Third quarter 1 July - 30 September 2009- Net sales for the third quarter amounted to SEK 38.7 million(33.6), an increase of SEK 5.1 million (15%) over the same period oflast year. Including early deliveries from the second quarter, salesrose by 31%.- Operating profit was SEK 6.4 million (5.8), an increase of SEK 0.6million.- Profit before tax was SEK 11.3 million (6.5), an increase of SEK4.8 million.- Due to the earlier cumulative loss carry forward, BioGaia pays notax. Profit after reported tax was SEK 7.7 million (9.0), a decreaseof SEK 1.3 million. The period's reported tax expense of SEK 3.6million refers to a change in the deferred tax asset. Profit for thecorresponding period of last year included a deferred tax benefit ofSEK 2.5 million.Key events in the third quarter of 2009- Agreement with Laboratoires BIOETHIC for the sale of BioGaia'sProbiotic tablets and drops in France.Key events after the end of the reporting period- Agreement with Pharma Nord for the sale of BioGaia's Probiotictablets and drops in Denmark.".we are continuing to see very satisfactory growth with sustainedgross margins and a strong cash flow. In the first three quarters ofthe year our sales rose by 43%, a trend that reflects the risingdemand we are noting in various markets and the pace of our productlaunches. It is also satisfying that the BioGaia brand accounted fora full 32% of our sales of finished consumer products, which is theresult of a deliberate focus on developing our own brand." saysManaging Director Peter Rothschild.For additional information contact:Peter Rothschild, Managing Director, telephone +46 8 - 555 293 00Jan Annwall, Deputy Managing Director, telephone +46 8 - 555 293 00(Figures in brackets refer to the same period of last year)http://hugin.info/86913/R/1349311/325129.pdfThis announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.
Datum: 22.10.2009 - 08:16 Uhr
Sprache: Deutsch
News-ID 7253
Anzahl Zeichen: 0
contact information:
Town:
London
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 261 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Interim report 1 January - 30 September 2009"
steht unter der journalistisch-redaktionellen Verantwortung von
BioGaia AB (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
